• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Psychosom Res . Psychological and medical outcomes of post-COVID-19 patients: A longitudinal study

tetano

Editor, Senior Moderator
J Psychosom Res


. 2026 Jun 28:210:112913.
doi: 10.1016/j.jpsychores.2026.112913. Online ahead of print.
Psychological and medical outcomes of post-COVID-19 patients: A longitudinal study

Agata Benfante[SUP] 1 [/SUP], Marialaura Di Tella[SUP] 2 [/SUP], Chiara Chiappero[SUP] 3 [/SUP], Claudia Nocera[SUP] 3 [/SUP], Georgia Zara[SUP] 4 [/SUP], Carlo Albera[SUP] 5 [/SUP], Paolo Solidoro[SUP] 5 [/SUP], Lorys Castelli[SUP] 1 [/SUP]


Affiliations
Abstract

Background: The coronavirus disease (COVID-19) pandemic affected different populations from a physical and psychological point of view. Psychological characteristics can have an impact on adjustment to illness conditions and increase the risk of persistence of physical symptoms and psychopathology. This prospective study examined possible changes in psychological and medical symptoms in people with post-COVID-19 condition by looking at which investigated variables could significantly predict anxiety and depressive symptoms at a long-term follow-up.
Methods: A baseline assessment (T0: 3-6 months after hospital discharge and virological recovery) and a second evaluation (T1: 9-16 months after virological recovery) were included. A total of 155 participants completed T0 evaluation by filling in questionnaires assessing resilience, difficulties in emotion regulation, fatigue, anxiety, depressive and post-traumatic stress symptoms (PTSS), while 84 participants also completed T1 evaluation.
Results: Participants reported lower scores in fatigue, depression and anxiety symptoms, and PTSS at T1 with respect to T0. PTSS and resilience evaluated at the baseline were found to be significant predictors of both anxiety and depressive symptoms measured at T1.
Conclusions: PTSS and resilience at baseline affected people with post-COVID-19 condition in relation to anxiety and depression in the medium term after virological recovery. Despite the high percentage of dropouts, which may have introduced attrition bias, the results highlight the importance of monitoring the psychological state of people with post-COVID-19 condition during clinical follow-up to identify those at higher risk of developing chronic anxiety and depressive symptoms at an early stage.

Keywords: Anxiety; Depression; Emotion regulation; Longitudinal study; Pneumology; Post-COVID-19 patients; Resilience.

 
Back
Top